AutoGenomics Inc.

Novel PCR based test detects Helicobacter pylori and resistance to clarithromycin in biopsy and stool

AutoGenomics launches INFINITI® H. pylori Assay for detection of Helicobacter pylori and mutations at 2142G & 2143G that are associated with antibiotic resistance

AutoGenomics, Inc., a leader in providing automated molecular testing solutions, announced today that it has introduced its CE-Marked INFINITI® Buccal Sample Collection Kit for the international market.

AutoGenomics, Inc., a leader in providing automated molecular testing solutions, announced today that it has entered into an agreement whereby McKesson Medical-Surgical Inc.

AutoGenomics, Inc., a leader in providing automated molecular testing solutions to clinical laboratories, announced today that it will showcase its “Sample-to-Result” NextGen automation platform – INFINITI® SMART – at the American Association...

AutoGenomics, Inc., a leader in providing automated molecular testing solutions to clinical reference laboratories, announced today that it has been granted United States patent for Multi-Patient Array (MPA) technology, increasing its issued patent...

INFINITI® HCV Genotyping test is now available both in the United States and the global market

Vista, Calif -- AutoGenomics, Inc., announced today that it has named Salvatore V. Alberti as Chief Financial Officer.